| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/06/1991 | US5037958 Immunosuppressive factor |
| 08/06/1991 | US5037806 Biologically active method using somatotropins |
| 08/06/1991 | US5037760 Secretory signal selection vectors for extracellular protein synthesis bacilli |
| 08/06/1991 | US5037755 Crown gall |
| 08/06/1991 | US5037742 Pseudorabies virus recombinants and their use in the production of proteins |
| 08/06/1991 | US5037741 Dipeptides such as aspartame, diffusion across an ion-rejection membrane |
| 08/06/1991 | CA2035691A1 Process for preparing human factor viii and analogs of factor viii |
| 08/06/1991 | CA1287311C Recombinant dna provided with hepatitis b virus gene, mammalian cells transformed with cloned viral dna, and production of hepatitis b virus proteins |
| 08/05/1991 | CA2009281A1 Anti-idiotype antibodies reactive with shared idiotypes expressed by human lymphomas and auto-antibodies |
| 08/04/1991 | WO1991011520A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES |
| 08/03/1991 | WO1991011529A1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 08/03/1991 | WO1991011460A1 Hepatitis a vaccines |
| 08/03/1991 | CA2075038A1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 08/02/1991 | WO1991011464A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/02/1991 | CA2075298A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/01/1991 | WO1991011523A1 Strain ral-4, useful for production of small proteins and peptides |
| 08/01/1991 | WO1991011198A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | CA2073963A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | CA2070994A1 Ral-4, useful in the production of small proteins and peptides |
| 08/01/1991 | CA2035303A1 Tripeptidase |
| 08/01/1991 | CA2035200A1 Antibodies specifically recognizing somatotropin binding protein |
| 08/01/1991 | CA2035199A1 Temperature-stable becillus thuringiensis toxin |
| 07/31/1991 | WO1991011462A2 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/31/1991 | EP0439442A2 Factor x-laci hybrid protein |
| 07/31/1991 | EP0439117A1 Monoclonal antibodies which bind (E)-5-(2-bromovinyl)-arabinofuranosyluracil and diagnostic methods based thereon |
| 07/31/1991 | EP0439095A2 Therapeutic antibody based fusion proteins |
| 07/31/1991 | EP0439056A2 Coccidiosis vaccines |
| 07/31/1991 | EP0439048A2 Monoclonal antibody recognizing anthracycline glycoside specific epitope and hybridoma secerning said antibody |
| 07/31/1991 | EP0438813A1 A novel antibiotic, Deoxymulundocandin, a process for its production and its use as medicament |
| 07/31/1991 | CN1053446A Production of recombinant polypeptides by bovine species and transgenic methods |
| 07/31/1991 | CA2074361A1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/30/1991 | US5036003 Antibodies to VPF |
| 07/30/1991 | CA2035088A1 Human monoclonal antibodies for brain tumor diagnosis and therapy |
| 07/30/1991 | CA1287002C Chimeric plasmid vector |
| 07/27/1991 | WO1991011528A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | WO1991011519A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 07/27/1991 | WO1991011461A1 C4 binding protein fusion proteins |
| 07/27/1991 | WO1991011199A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2074512A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2073859A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 07/27/1991 | CA2073459A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2049964A1 C4 binding protein fusion proteins |
| 07/27/1991 | CA2034768A1 Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen |
| 07/25/1991 | WO1991010738A1 T cell growth factor |
| 07/25/1991 | WO1991010735A2 Human receptor of tsh. sequence coding for such receptor |
| 07/25/1991 | WO1991010728A1 Novel retroviral vectors |
| 07/25/1991 | WO1991010722A2 Chimeric immunoglobulin for cd4 receptors |
| 07/25/1991 | WO1991010682A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
| 07/25/1991 | WO1991010671A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/25/1991 | WO1991010438A1 Soluble t-cell antigen receptor chimeric antigens |
| 07/25/1991 | WO1991010369A1 Method for preparing an enzymatic hydrolyzate |
| 07/25/1991 | DE4001238A1 Verfahren zur anreicherung bzw. reinigung von biomolekuelen A method for enrichment or purification of biomolecules |
| 07/24/1991 | EP0438312A2 Recombinant human anti-CD18 antibodies |
| 07/24/1991 | EP0438310A1 Method for producing recombinant immunoglobuline |
| 07/24/1991 | EP0438232A2 Dna sequence conferring a plaque inhibition phenotype |
| 07/24/1991 | EP0438200A1 Method for the expression of heterologous genes in the yeast Pichia pastoris, expression vectors and transformed microorganisms |
| 07/24/1991 | EP0438102A1 Process for the production of antibodies |
| 07/24/1991 | EP0438053A1 Durable engraftment and development of human hematopoietic lineages in normal mammals |
| 07/24/1991 | EP0437687A2 Process for purification of a 69000 dalton antigenic protein from bordetella pertussis |
| 07/24/1991 | EP0437604A1 Recombinant poxvirus and streptococcal m protein vaccine |
| 07/24/1991 | EP0437516A1 H. saimiri-htlv-x region vector |
| 07/24/1991 | EP0437505A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 07/24/1991 | EP0437427A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
| 07/24/1991 | CN1053265A Human c3b/c4b receptor (cr1) |
| 07/23/1991 | WO1991010678A1 Method for recovering recombinant proteins |
| 07/23/1991 | CA2074250A1 Method for recovering recombinant proteins |
| 07/23/1991 | CA2032757A1 Monoclonal antibodies which bind (e)-5-(2-bromovinyl)-arabinofuranosyluracil and diagnostic method based thereon |
| 07/23/1991 | CA1286619C Cell line producing aids viral antigens without producing infectious virus particles |
| 07/23/1991 | CA1286605C Delayed solid phase immunologic assay |
| 07/20/1991 | WO1991010683A1 A platelet cell adhesion molecule and variants thereof |
| 07/20/1991 | WO1991010448A1 A cell surface antigen associated with cellular apoptosis |
| 07/20/1991 | CA2074072A1 Platelet cell adhesion molecule and variants thereof |
| 07/20/1991 | CA2034593A1 Recombinant human anti-cd18 antibodies |
| 07/20/1991 | CA2034574A1 Recombinant human anti-cd18 antibodies |
| 07/20/1991 | CA2034553A1 Method for producing recombinant immunoglobulins |
| 07/20/1991 | CA2034533A1 Retroviral vectors |
| 07/20/1991 | CA2033793A1 Dna sequence conferring a plaque inhibition phenotype |
| 07/20/1991 | CA2023561A1 Platelet cell adhesion molecule and variants thereof |
| 07/19/1991 | WO1991010677A1 Process for enriching or cleaning biomolecules |
| 07/19/1991 | CA2067790A1 Process for enriching or cleaning biomolecules |
| 07/19/1991 | CA2034385A1 Vector to produce biologically important peptides |
| 07/17/1991 | WO1991010742A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/17/1991 | EP0437367A2 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
| 07/17/1991 | EP0437244A1 Glidobactin PF-1 peptide antitumor antibiotics |
| 07/17/1991 | EP0436858A1 Promoter of glyceraldehyde-3-phosphate dehydrogenase gene and its use |
| 07/17/1991 | EP0436648A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 07/17/1991 | EP0436634A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| 07/17/1991 | EP0436625A1 Mixed feed recombinant yeast fermentation |
| 07/17/1991 | EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 07/17/1991 | EP0436537A1 Recombinant cmv neutralizing proteins |
| 07/17/1991 | CA2073060A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/16/1991 | US5032574 Novel antimicrobial peptide |
| 07/16/1991 | US5032521 Antitumor |
| 07/16/1991 | US5032504 Diagnostic test kit and method for determination of chlamydial or gonococcal antigens using a microporous membrane |
| 07/16/1991 | CA1286238C Anti-epiglycanin monoclonal antibodies |
| 07/13/1991 | WO1991010741A1 Generation of xenogeneic antibodies |
| 07/13/1991 | CA2050918A1 Generation of xenogeneic antibodies |
| 07/12/1991 | CA2033928A1 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
| 07/11/1991 | WO1991009969A1 Novel antihuman thrombomodulin monoclonal antibody and diagnosis of endothelial disorder by enzyme immunoassay |
| 07/11/1991 | WO1991009967A1 Humanised antibodies |